Management of gastric polyps: an endoscopy-based approach.
暂无分享,去创建一个
Massimo Rugge | D. Graham | M. Rugge | R. Genta | Y. Shaib | David Y Graham | Robert M Genta | Yasser H Shaib
[1] A. Nishio,et al. Characteristic endosonographic features of gastric inflammatory fibroid polyps. , 2001, Endoscopy.
[2] M. Stolte. Hyperplastic polyps of the stomach: associations with histologic patterns of gastritis and gastric atrophy. , 2001, The American journal of surgical pathology.
[3] G. Qvigstad,et al. Serum gastrin and chromogranin A levels in patients with fundic gland polyps caused by long-term proton-pump inhibition , 2008, Scandinavian journal of gastroenterology.
[4] R. Allibone,et al. Multiple and recurrent inflammatory fibroid polyps in a Devon family ('Devon polyposis syndrome'): an update. , 1992, Gut.
[5] L. Grimelius,et al. Gastric Carcinoids: Biologic Behavior and Prognosis After Differentiated Treatment in Relation to Type , 2005, Annals of surgery.
[6] T. Sakurazawa,et al. Disappearance of Hyperplastic Polyps in the Stomach after Eradication of Helicobacter pylori , 1998, Annals of Internal Medicine.
[7] M. Stolte,et al. Frequency, Location, and Age and Sex Distribution of Various Types of Gastric Polyp , 1994, Endoscopy.
[8] A. Spigelman,et al. Upper gastrointestinal pathology in familial adenomatous polyposis: results from a prospective study of 102 patients. , 1990, Journal of clinical pathology.
[9] J. Stoner,et al. Multicenter Experience with Upper Gastrointestinal Polyps in Pediatric Patients with Familial Adenomatous Polyposis , 2004, American Journal of Gastroenterology.
[10] M. Rugge,et al. Gastric epithelial dysplasia. How clinicopathologic background relates to management , 1995, Cancer.
[11] N. Ahmed,et al. Fracture Risk and Bone Mineral Density Reduction Associated with Proton Pump Inhibitors , 2012, Pharmacotherapy.
[12] K. Lapane,et al. Proton pump inhibitors are associated with a high rate of serious infections in veterans with decompensated cirrhosis , 2012, Alimentary pharmacology & therapeutics.
[13] H. Chae,et al. [Spontaneous resolution of multiple fundic gland polyps after cessation of treatment with omeprazole]. , 2008, The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi.
[14] A. Zangrandi,et al. Natural history, clinicopathologic classification and prognosis of gastric ECL cell tumors. , 1998, The Yale journal of biology and medicine.
[15] R. Jensen,et al. NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas. , 2010, Pancreas.
[16] Ming-Tsan Lin,et al. Gastric outlet obstruction due to giant hyperplastic gastric polyps. , 2005, Journal of the Formosan Medical Association = Taiwan yi zhi.
[17] T. Nakayama,et al. Carcinoma in gastric hyperplastic polyps. A phenotypic study. , 1996, Digestive diseases and sciences.
[18] M. Stolte,et al. Gastric Carcinoids and Neuroendocrine Carcinomas: Pathogenesis, Pathology, and Behavior , 1996, World Journal of Surgery.
[19] K. Okazaki,et al. Atypical EUS features of gastric inflammatory fibroid polyps. , 2005, Gastrointestinal endoscopy.
[20] M. Rugge,et al. The long term outcome of gastric non-invasive neoplasia , 2003, Gut.
[21] D. Graham,et al. Gastritis staging in clinical practice: the OLGA staging system , 2006, Gut.
[22] S. Jensen,et al. The clopidogrel-PPI interaction: an updated mini-review. , 2012, Current vascular pharmacology.
[23] E. G. Hahn,et al. Diagnostic accuracy of forceps biopsy versus polypectomy for gastric polyps: a prospective multicentre study , 2002, Gut.
[24] H. Mitomi,et al. p53, but not c-Ki-ras, mutation and down-regulation of p21WAF1/CIP1 and cyclin D1 are associated with malignant transformation in gastric hyperplastic polyps. , 2001, American journal of clinical pathology.
[25] B. Rovner,et al. Randomized clinical trial: a pilot study investigating the safety and effectiveness of an escalating dose of peginterferon &agr;-2a monotherapy for 48 weeks compared with standard clinical care in patients with hepatitis C cirrhosis , 2012, European journal of gastroenterology & hepatology.
[26] M. Stolte,et al. Why is the hyperplastic polyp a marker for the precancerous condition of the gastric mucosa? , 2005, Virchows Archiv.
[27] R. Genta,et al. Reactive gastropathy is associated with inflammatory conditions throughout the gastrointestinal tract , 2012, Alimentary pharmacology & therapeutics.
[28] J. Lasota,et al. Gastrointestinal stromal tumors – definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis , 2000, Virchows Archiv.
[29] P. Sipponen,et al. Gastric polyps; their morphological and endoscopical characteristics and relation to gastric carcinoma. , 2009, Acta pathologica, microbiologica, et immunologica Scandinavica. Section A, Pathology.
[30] R. DeMatteo,et al. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. , 2000, Annals of surgery.
[31] C. O'Morain,et al. Review article: the long‐term use of proton‐pump inhibitors , 2005, Alimentary pharmacology & therapeutics.
[32] A. D. Van den Abbeele,et al. NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)--update of the NCCN clinical practice guidelines. , 2007, Journal of the National Comprehensive Cancer Network : JNCCN.
[33] R. Seruca,et al. Microsatellite instability in hyperplastic and adenomatous polyps of the stomach , 1999, Cancer.
[34] Tomoyuki Shibata,et al. Correlation between magnifying narrow band imaging and histopathology in gastric protruding/or polypoid lesions: a pilot feasibility trial , 2012, BMC Gastroenterology.
[35] Robert M. Genta,et al. Management of gastric polyps: a pathology-based guide for gastroenterologists , 2009, Nature Reviews Gastroenterology &Hepatology.
[36] Laura K. Bianchi,et al. Fundic gland polyp dysplasia is common in familial adenomatous polyposis. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[37] L. Pantanowitz,et al. Inflammatory Fibroid Polyps of the Gastrointestinal Tract: Evidence for a Dendritic Cell Origin , 2004, The American journal of surgical pathology.
[38] D. Lam-Himlin. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED) , 2013 .
[39] N. Vakil. Prescribing Proton Pump Inhibitors , 2012, Drugs.
[40] Erik C von Rosenvinge,et al. Gastric masses in multiple endocrine neoplasia type I-associated Zollinger-Ellison syndrome. , 2009, Gastroenterology.
[41] T. Nakajima,et al. High incidence of microscopic gastrointestinal stromal tumors in the stomach. , 2006, Human pathology.
[42] G. Qvigstad,et al. Treatment of gastric carcinoids type 1 with the gastrin receptor antagonist netazepide (YF476) results in regression of tumours and normalisation of serum chromogranin A , 2012, Alimentary pharmacology & therapeutics.
[43] M. P. Leòn,et al. Dysplastic changes in gastric fundic gland polyps of patients with familial adenomatous polyposis. , 1999, Italian journal of gastroenterology and hepatology.
[44] J. Misdraji,et al. Reply , 1991, Gut.
[45] Amitabh Srivastava,et al. Gastric preneoplastic lesions and epithelial dysplasia. , 2007, Gastroenterology clinics of North America.
[46] M. Saboorian,et al. The Current Spectrum of Gastric Polyps: A 1-Year National Study of over 120,000 Patients , 2009, The American Journal of Gastroenterology.
[47] A. Axon,et al. Reflux gastritis: distinct histopathological entity? , 1986, Journal of clinical pathology.
[48] B. Nilsson,et al. Adjuvant imatinib treatment improves recurrence-free survival in patients with high-risk gastrointestinal stromal tumours (GIST) , 2007, British Journal of Cancer.
[49] G. Nakano,et al. Histopathological classification and malignant change in gastric polyps. , 1985, Journal of clinical pathology.
[50] H. Mischinger,et al. Pyloric obstruction caused by prolapse of a hyperplastic gastric polyp. , 2002, Hepato-Gastroenterology.
[51] L. Villani,et al. Session 5: Morphology and Pathogenesis of Endocrine Hyperplasias, Precarcinoid Lesions, and Carcinoids Arising in Chronic Atrophic Gastritis , 1991 .
[52] R. Schulick,et al. Management of gastrointestinal stromal tumors. , 2008, The Surgical clinics of North America.
[53] Christopher B. Tan,et al. Gastrointestinal Stromal Tumors: A Review of Case Reports, Diagnosis, Treatment, and Future Directions , 2012, ISRN gastroenterology.
[54] T. Sano,et al. CD34 expression by inflammatory fibroid polyps of the stomach. , 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[55] D. Graham,et al. Fundic gland polyps developing during omeprazole therapy. , 1997, The American journal of gastroenterology.
[56] A. Nasierowska-Guttmejer. [Neuroendocrine neoplasms of the stomach]. , 2013, Polish journal of pathology : official journal of the Polish Society of Pathologists.
[57] J. Lasota,et al. Gastrointestinal stromal tumors: pathology and prognosis at different sites. , 2006, Seminars in diagnostic pathology.
[58] R. Mårvik,et al. Gastric carcinoids after long‐term use of a proton pump inhibitor , 2012, Alimentary pharmacology & therapeutics.
[59] G. Klöppel,et al. The Gastroenteropancreatic Neuroendocrine Cell System and Its Tumors: The WHO Classification , 2004, Annals of the New York Academy of Sciences.
[60] M. Rugge,et al. Gastric epithelial dysplasia in the natural history of gastric cancer: a multicenter prospective follow-up study. Interdisciplinary Group on Gastric Epithelial Dysplasia. , 1994, Gastroenterology.
[61] T. Hattori. Morphological range of hyperplastic polyps and carcinomas arising in hyperplastic polyps of the stomach. , 1985, Journal of clinical pathology.
[62] O. Louthan. Neuroendocrine neoplasms of the stomach. , 2013, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.
[63] L. Villani,et al. Morphology and pathogenesis of endocrine hyperplasias, precarcinoid lesions, and carcinoids arising in chronic atrophic gastritis. , 1991, Scandinavian journal of gastroenterology. Supplement.
[64] M. Stolte,et al. ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis. , 1999, Gastroenterology.
[65] J. Meyerhardt,et al. A prospective phase II study of 2-methoxyestradiol administered in combination with bevacizumab in patients with metastatic carcinoid tumors , 2011, Cancer Chemotherapy and Pharmacology.
[66] J. Kupryjańczyk,et al. Malignant transformation of gastric hyperplastic polyps. , 2002, American journal of clinical pathology.
[67] E. Wardelmann,et al. Inflammatory fibroid polyps harbour mutations in the platelet‐derived growth factor receptor alpha (PDGFRA) gene , 2008, The Journal of pathology.
[68] S. Wahl,et al. p53 expression in precancerous gastric lesions: an immunohistochemical study of PAb 1801 monoclonal antibody on adenomatous and hyperplastic gastric polyps. , 1993, The American journal of gastroenterology.
[69] K. Okazaki,et al. Endoscopic features of gastric inflammatory fibroid polyps. , 1996, The American journal of gastroenterology.
[70] M. Hongo,et al. Incidence and risk factor of fundic gland polyp and hyperplastic polyp in long-term proton pump inhibitor therapy: a prospective study in Japan , 2010, Journal of Gastroenterology.
[71] D. Graham,et al. Helicobacter pylori diagnosis and management. , 2006, Gastroenterology clinics of North America.
[72] M F Dixon,et al. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. , 1996, The American journal of surgical pathology.
[73] C. Antonescu,et al. Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial , 2009, The Lancet.
[74] R. Genta,et al. No association between gastric fundic gland polyps and gastrointestinal neoplasia in a study of over 100,000 patients. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[75] N. Abraham. Proton pump inhibitors: potential adverse effects , 2012, Current opinion in gastroenterology.
[76] J. Lasota,et al. Histopathology of gastrointestinal stromal tumor , 2011, Journal of surgical oncology.
[77] K. Elster. Histologic classification of gastric polyps. , 1976, Current topics in pathology. Ergebnisse der Pathologie.
[78] E. Kuipers,et al. The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis. , 2010, Gastrointestinal endoscopy.
[79] Tsung-Teh Wu,et al. Genetic Alterations in Gastric Adenomas of Intestinal and Foveolar Phenotypes , 2003, Modern Pathology.
[80] L. Anemona,et al. Inflammatory fibroid polyp. A case report and review of the literature. , 2012, Annali italiani di chirurgia.
[81] L. Poritz,et al. PPI Therapy and Albumin are Better Predictors of Recurrent Clostridium difficile Colitis than Choice of Antibiotics , 2012, Journal of Gastrointestinal Surgery.
[82] T. Viset,et al. Gastric neuroendocrine carcinoma after long-term use of proton pump inhibitor , 2012, Scandinavian journal of gastroenterology.
[83] D. Graham,et al. Noninvasive versus histologic detection of gastric atrophy in a Hispanic population in North America. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[84] P. Davaris,et al. Gastric epithelial polyps: a retrospective endoscopic study of 12974 symptomatic patients. , 1996, The Italian journal of gastroenterology.